Jeremy Skillington of Poolbeg: This is a key step in the creation of a Phase I clinical trial ready oral vaccine candidate

Dr. Jeremy Skillington, Chief Executive Officer of Poolbeg Pharma #POLB provides an update on the company’s led EncOVac Consortium Oral Vaccine Programme, which he says is a key step in the creation of a Phase I clinical trial ready oral vaccine candidate

To read the full RNS click here